Lymphocyte recognition of picornaviruses

References

1. Acharya R., Fry E., Stuart D., Fox G., Rolands D., Brown F. 1989; The three dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337:709–716
   [Google Scholar]
2. Auvinen P., Makela M. J., Roivainen M., Kallaioki M., Vainionpaa R., Hyypia T. 1993; Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides. Acta Pathologica Micro-biologica et Immunologica Scandinavica 101:517–528
   [Google Scholar]
3. Barnett D. C., Burt D. S., Graham C. M., Warren A. P., Skehel J. J., Thomas D. B. 1989; I-A^d Restricted T cell recognition of influenza hemaglutinin. Journal of Immunology 143:2663–2669
   [Google Scholar]
4. Beatrice S. T., Katze M. G., Zajac B. A., Crowell R. L. 1980; Induction of neutralizing antibodies by the coxsackievirus B3 virion polypeptide VP2. Virology 104:426–438
   [Google Scholar]
5. Blondel B., Crainic R., Fichot O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. 1986; Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody binding site. Journal of Virology 57:81–90
   [Google Scholar]
6. Boege U., Kobasa D., Onodera S., Parks G. D., Palmenberg A. C., Scraba D. G. 1991; Characterization of Mengo virus neutralization epitopes. Virology 181:1–13
   [Google Scholar]
7. Collen T. 1991 T Cell responses of cattle to foot-and-mouth disease virus PhD thesis CNAA/AFRC Institute for Animal Health, Pirbright Laboratory; Pirbright, UK.:
   [Google Scholar]
8. Collen T., Doel T. R. 1990; Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. Journal of General Virology 71:309–315
   [Google Scholar]
9. Collen T., Pullen L., Doel T. R. 1989; T Cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. Journal of General Virology 70:395–403
   [Google Scholar]
10. Collen T., DiMarchi R., Doel T. R. 1991; A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. Journal of Immunology 146:749–755
    [Google Scholar]
11. Crane M. A., Jue C., Mitchell M., Lipton H., Kim B. S. 1990; Detection of restricted predominant epitopes of Theiler’s murine encephalomyelitis virus capsid proteins expressed in the lgt11 system: differential patterns of antibody reactivity among different mouse strains. Journal of Neuroimmunology 27:173–186
    [Google Scholar]
12. Crowther J. R., Farias S., Carpenter W. C., Samuel A. R. 1993; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Journal of General Virology 74:1547–1553
    [Google Scholar]
13. Diamond D. C., Jameson B. A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A., Osterhaus A. D. M. E., Crainic R., Wimmer E. 1985; Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229:1090–1093
    [Google Scholar]
14. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. 1989; Structural factors that control conformation transitions and serotype specificity in type 3 poliovirus. EMBO Journal 8:1567–1579
    [Google Scholar]
15. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
16. Gerety S. J., Clatch R. J., Lipton H. L., Goswami R. G., Rundell M. K., Miller S. D. 1991; Class Il-restricted T cell responses in Theiler’s murine encephalomyelitis virus-induced demyelinating disease. Journal of Immunology 146:2401–2408
    [Google Scholar]
17. Gerety S. J., Karpus W. J., Cubbon A. R., Goswami R. G., Rundell M. K., Peterson J. D., Miller S. D. 1994; Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus-induced demyelinating disease, V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. Journal of Immunology 152:908–918
    [Google Scholar]
18. Glass E. J., Oliver R. A., Collen T., Doel T. R., DiMarchi R., Spooner R. L. 1991; MHC class II recognition of FMDV peptides by bovine T cells. Immunology 74:594–599
    [Google Scholar]
19. Graham S., Wang E. C. Y., Jenkins O., Borysiewicz L. K. 1993; Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B cell epitopes in poliovirus. Journal of Virology 67:1627–1637
    [Google Scholar]
20. Grant R. A., Filman D. J., Fujinami R. S., Icenogle J. P., Hogle J. M. 1992; Three-dimensional structure of Theiler virus. Proceedings of the National Academy of Sciences, USA 89:2061–2065
    [Google Scholar]
21. Harmon S. A., Broman B., Powdrill T. F., Johnston J. M., Ehrenfeld E., Summers D. F. 1993; Localization of a priming epitope to the C-terminal portion of hepatitis A virus VP1. Journal of Infectious Diseases 167:990–992
    [Google Scholar]
22. Hastings G. Z., Francis M. J., Rowlands D. J., Chain B. M. 1993; Epitope analysis of the T cell response to a complex antigen: proliferative response to human rhinovirus capsids. European Journal of Immunology 23:2300–2305
    [Google Scholar]
23. Hogle J. M., Filman D. J. 1989; The antigenic structure of poliovirus. Philosophical Transactions of the Royal Society of London B323:167–178
    [Google Scholar]
24. Huber S. A., Job L. P., Woodruff J. F. 1980; Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. American Journal of Pathology 98:681–694
    [Google Scholar]
25. Huber S., Polgar J., Moraska A., Cunningham M., Schwimmbeck P., Schultheiss P. 1993; T Lymphocyte responses in CVB3-induced murine myocarditis. Scandinavian Journal of Infectious Diseases Suppl 88:67–78
    [Google Scholar]
26. Katrak K., Mahon B. P., Minor P. D., Mills K. H. G. 1991; Cellular and humoral immune responses to poliovirus in mice: a role for helper T cells in heterotypic immunity to poliovirus. Journal of General Virology 72:1093–1098
    [Google Scholar]
27. Kim B. S., Choe Y.-K., Crane W. A., Jue C. R. 1992; Identification and localization of a limited number of predominant conformation-independent antibody epitopes of Theiler’s murine encephalomyelitis virus. Immunology Letters 31:199–206
    [Google Scholar]
28. Kitson J. D. A., McCahon D., Belsham G. J. 1990; Sequence analysis of moclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
    [Google Scholar]
29. Kobasa D., Muir S., Bittle J. L., Scraba D. G. 1993; Mapping the T-cell determinants on the Mengo virion. IXth International Congress of Virology 238: abstract P31–27
    [Google Scholar]
30. Kutubuddin M., Simons J., Chow M. 1992a; Identification of T-helper epitopes in the capsid proteins of poliovirus. Journal of Virology 66:3042–3047
    [Google Scholar]
31. Kutubuddin M., Simons J., Chow M. 1992b; Poliovirus-specific major histocompatibility complex class-I restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions. Journal of Virology 66:5967–5974
    [Google Scholar]
32. Leclerc C., Deriaud E., Mimic V., van der Werf S. 1991; Identification of a T cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Journal of Virology 65:711–718
    [Google Scholar]
33. Li Q., Yafal A. G., Lee Y. M., Hogle J., Chow M. 1994; Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. Journal of Virology 68:3965–3970
    [Google Scholar]
34. Lindsley M. D., Thiemann R., Rodriguez M. 1991; Cytotoxic T cells isolated from the central nervous system of mice infected with Theiler’s virus. Journal of Virology 65:6612–6620
    [Google Scholar]
35. Liu Y., Mu G.-F., Lu H., Gu F.-Z. 1988; Characterization of VP1 as immunodominant antigen of enterovirus type 70 and antigenic analysis of virus strains by monoclonal antibodies. Chinese Medical Journal 101:20–24
    [Google Scholar]
36. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. 1993; Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362:566–568
    [Google Scholar]
37. Luo M., Rossman M. G., Palmenberg A. C. 1988; Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology 166:503–514
    [Google Scholar]
38. Luo M., He C., Toth K. S., Zhang C. X., Lipton H. L. 1992; Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proceedings of the National Academy of Sciences, USA 89:2409–2413
    [Google Scholar]
39. McCahon D., Crowther J. R., Belsham G. J., Kitson J. D. A., Duchesne M., Have P., Meloen R. H., Morgan D. O., De Simone F. 1989; Evidence for at least four antigenic sites on type 1 foot-and-mouth disease virus involved in neutralization: identification by single and multiple site monoclonal antibody-resistant mutants. Journal of General Virology 70:639–645
    [Google Scholar]
40. Mahon B. P., Katrak K., Mills K. H. G. 1992; Antigenic sequences of poliovirus recognised by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4⁺ T cell clones. Journal of Virology 66:7012–7020
    [Google Scholar]
41. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principle and subsiduary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
    [Google Scholar]
42. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986; Antigenic structure of polioviruses of serotypes 1. 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
43. Muir S., Weintraub J. P., Hogle J., Bittle J. L. 1991; Neutralizing antibody to Mengo virus, induced by synthetic peptides. Journal of General Virology 72:1087–1092
    [Google Scholar]
44. Nainan O. V., Brinton M. A., Margolis H. S. 1992; Identification of amino acids located in the antibody binding sites of hepatitis A virus. Virology 191:984–987
    [Google Scholar]
45. Ohara Y., Senkowski A., Fu J., Klaman L., Goodall J., Toth M., Roos R. P. 1988; Trypsin-sensitive neutralization site on VP1 of Theiler’s murine encephalomyelitis viruses. Journal of Virology 62:3527–3529
    [Google Scholar]
46. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Ruekert R. R., Chow M. 1988; Three dimensional structure of poliovirus serotype 1 neutralizing determinants. Journal of Virology 62:1781–1794
    [Google Scholar]
47. Palmenberg A. C. 1989; Sequence alignments of picornaviral capsid proteins. In Molecular Aspects of Picornaviral Infection and Detection pp 211–241 Edited by Semler B. L., Ehrenfeld E. Washington, DC: American Society for Microbiology;
    [Google Scholar]
48. Patel V., Ferguson M., Minor P. D. 1993; Antigenic sites on type 2 poliovirus. Virology 192:361–364
    [Google Scholar]
49. Pena-Rossi C., McAllister A., Fiette L., Brahic M. 1991; Theiler’s virus infection induces a specific cytotoxic T lymphocyte response. Cellular Immunology 138:341–348
    [Google Scholar]
50. Pevear D. C., Luo M., Lipton H. L. 1988; Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid differences identifies possible locations of immunogenic sites on the virion. Proceedings of the National Academy of Sciences, USA 85:4496–4500
    [Google Scholar]
51. Pfaff E., Muller H., Haas B., Thiel H. J. 1989; Molecular and immunological analysis of foot-and-mouth disease virus mutants. In Vaccines 89 pp 449–455 Edited by Lerner R. A., Ginsberg H., Chanock R. M., Brown F. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
52. Ping L.-H., Lemon S. M. 1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. Journal of Virology 66:2208–2216
    [Google Scholar]
53. Ping L.-H., Jansen R. W., Stapleton J. T., Cohen J. I., Lemon S. M. 1988; Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proceedings of the National Academy of Sciences, USA 85:8281–8285
    [Google Scholar]
54. Prabhakar B. S. 1988; Application of monoclonal antibodies to the study of coxsackieviruses. In Coxsackieviruses - A General Update pp 117–134 Edited by Bendinelli M., Friedmann H. New York: Plenum Press;
    [Google Scholar]
55. Reimann B.-Y., Zell R., Kandolf R. 1991; Mapping of a neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera. Journal of Virology 65:3475–3480
    [Google Scholar]
56. Rossman M. G. 1989; The canyon hypothesis. Hiding the host cell receptor attachment site on the viral surface from immune surveillance. Journal of Biological Chemistry 264:14587–14590
    [Google Scholar]
57. Rossman M. G., Arnold E., Erikson J. W., Frankenberger E. A., Griffith J. P., Hecht H. J., Johnson J. E., Kamer G., Luo M., Mosser A. G., Ruekert R. R., Sherry B., Vriend G. 1985; Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145–153
    [Google Scholar]
58. Sercarz E. E., Lehmann P. V., Ametani A., Benichou G., Miller A., Moudgil K. 1993; Dominance and crypticity of T cell antigenic determinants. Annual Review of Immunology 11:729–766
    [Google Scholar]
59. Sherry B., Mosser A. G., Colonno R. J., Ruekert R. R. 1986; Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus-14. Journal of Virology 57:246–257
    [Google Scholar]
60. Simons J., Kutubuddin M., Chow M. 1993; Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. Journal of Virology 67:1262–1268
    [Google Scholar]
61. Smyth M. C., Hoey E. M., Trudgett A., Martin S. J., Brown F. 1990; Chemically synthesized peptides elicit neutralizing antibody to bovine enterovirus. Journal of General Virology 71:231–234
    [Google Scholar]
62. Smyth M. C., Trudgett A., Hoey E. M., Martin S. J., Brown F. 1992; Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides. Archives of Virology 126:21–33
    [Google Scholar]
63. Stanway G. 1990; Structure, function and evolution of picornaviruses. Journal of General Virology 71:2483–2501
    [Google Scholar]
64. Stapleton J. T., Lemon S. M. 1987; Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. Journal of Virology 61:491–498
    [Google Scholar]
65. Stave J. W., Card J. L., Morgan D. O., Vakharia V. N. 1988; Neutralization sites of type Ol foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 162:21–29
    [Google Scholar]
66. Thomas A. A. M., Woortmeuer R. J., Puuk W., Barteling S. J. 1988; Antigenic sites on foot-and-mouth disease virus type O10. Journal of Virology 62:2782–2789
    [Google Scholar]
67. Vallbracht A., Maier K., Stierhof Y. D., Wiedmann K. H., Flehming B., Fleischer B. 1989; Liver-derived cytotoxic T cells in hepatitis A virus infection. Journal of Infectious Diseases 160:209–217
    [Google Scholar]
68. Weigers K., Uhlig H., Dernick R. 1989; N-AglB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 containing residues 96-104 and 141–152. Virology 170:583–586
    [Google Scholar]
69. Weigers K. J., Wetz K., Dernick R. 1990; Molecular basis for linkage of a continuous and discontinuous and neutralization epitope on the structural polypeptide VP2 of poliovirus type 1. Journal of Virology 64:1283–1289
    [Google Scholar]
70. Wiley J. A., Hamel J., Brodeur B. R. 1992; Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus-70 conformational epitopes. Journal of Virology 66:5744–5751
    [Google Scholar]
71. Xie Q.-C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Journal of General Virology 68:1637–1647
    [Google Scholar]
72. Zurbriggen A., Fujinami R. S. 1989; A neutralization-resistant Theiler’s virus produces an altered disease pattern in the mouse CNS. Journal of Virology 63:1505–1513
    [Google Scholar]
73. Zurbriggen A., Thomas C., Yamada M., Roos R. P., Fujinami R. S. 1991a; Direct evidence for a role for amino acid 101 of VP1 in central nervous system disease in Theiler’s murine encephalomyelitis virus. Journal of Virology 65:1929–1937
    [Google Scholar]
74. Zurbriggen A., Yamada M., Thomas C., Fujinami R. S. 1991b; Restricted viral replication in the spinal cords of nude mice infected with a Theiler’s virus variant. Journal of Virology 65:1023–1030
    [Google Scholar]